Trimethaphan for High Blood Pressure

"This clinical trial seeks to enrol 12 individuals affected by hypertension in the age range of 18-65. Eligible applicants must be comprised of a combination of genders, races and body types. In addition, candidates for this study must have blood pressure readings greater than or equal to 140/90 mm Hg taken from two different occasions while seated as well as demonstrate their ability and willingness to provide informed consent."

"Currently, seven clinical trials are being conducted with Trimethaphan. None of them have entered their final phase yet. Most tests for this treatment take place in New York City, but other US cities such as Miami and San Francisco also offer it."

"According to clinicaltrials.gov, the recruitment process for this medical trial is ongoing. The study was initially uploaded on April 1st 2015 and recently updated August 21st 2022."

"This trial is open to anyone aged 18-65, with 55 clinical trials designated for those younger than the age of consent and an additional 666 studies available for participants over 65 years old."

"Trimethaphan is commonly used to manage myocardial infarction but can be employed for various other purposes such as treating anal fissure, angina attacks, and pain."

"Affirmative. Per the information published on clinicaltrials.gov, this medical trial is still recruiting participants and began doing so since April 1st 2015. The latest update was posted on August 21st 2022 and 12 patients are needed from one site only."

"Our team at Power assigned Trimethaphan a safety score of 1, as this is an early Phase 1 trial with limited evidence for both efficacy and security."